Proteon Therapeutics Funding: $185M Raised, Series A (2017)
Proteon Therapeutics is based in Waltham, Massachusetts. It has raised $185M in total funding. Latest round: Series A. Backed by Deerfield Management.
Proteon Therapeutics funding overview
Proteon Therapeutics is based in Waltham, Massachusetts. Proteon Therapeutics has raised $185M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2017. The round record for Proteon Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include Deerfield Management.
Proteon Therapeutics at a glance
Total raised
$185M
Latest round
Series A
Latest round date
June 2017
Headquarters
Waltham, Massachusetts
Notable investors
Deerfield Management
Frequently asked about Proteon Therapeutics funding
How much has Proteon Therapeutics raised?
Proteon Therapeutics has raised $185M in total disclosed funding across the rounds on record.
Who has invested in Proteon Therapeutics?
Deerfield Management are named among the investors backing Proteon Therapeutics.
What was the latest Proteon Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2017.
Where is Proteon Therapeutics based?
Proteon Therapeutics is based in Waltham, Massachusetts.
When did Proteon Therapeutics last raise?
The last disclosed Proteon Therapeutics round closed in June 2017 at Series A.
We update the Proteon Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.
